Quidel | QDEL - 营业费用

金融业

USD

USD 5.77B

现金及等价物

USD 169.8M

USD 448.8M

USD 1.45B

USD 966.1M

USD 2.84B

USD -37.3M

USD 153.3M

6.6K

EPS每股收益

USD 0.46

股本和储备

USD 1.92B

USD 274.8M

债务利息支出

USD 5.68B

USD -10.78

USD 2.47B

USD 925.9M

USD -733M

USD 760.9M

USD -37.3M

普通股股本

USD 67.9M

2.03

USD -756.9M

USD 724M

销售和管理费用

USD 194.4M

USD 577.6M

贸易债权人

USD 279.4M

应收帐款人

USD 417M

	营业费用	更改		日
Abbott	USD 9.21B		17M	2025-12
Agilent	USD 1.44B		27M	2025-12
Avanos Medical	USD 156.13M		2.7M	2025-12
Becton, Dickinson and Co.	USD 4.59B		476M	2025-12
Bruker	USD 900.9M		124.3M	2025-12
Cerus	USD 34.78M		2.98M	2024-12
Charles River Laboratories	USD 918.41M		2.49B	2025-12
Danaher	USD 5.34B		45.74B	2025-12
Haemonetics	USD 134.99M		1.26M	2025-12
Hologic	USD 349.4M		447.1M	2025-12
Illumina	USD 903M		69M	2025-12
IQVIA Holdings	USD 1.69B		4.47B	2025-12
Merit Medical Systems	USD 339.74M		1.8M	2025-12
Mettler Toledo International	USD 777.8M		42.3M	2025-12
Myriad Genetics	USD 212.8M		16.2M	2025-12
Neogen	USD 214.5M		15.57M	2025-12
OraSure Technologies	USD 40.35M		2.45M	2025-12
Pacific Biosciences Of California	USD 97.83M		41.29M	2025-12
Quidel	USD 760.9M		1.28B	2025-12
Revvity	USD 626.22M		25.62M	2025-12
STAAR Surgical	USD 68.74M		1.55M	2025-12
Thermo Fisher Scientific	USD 9.91B		867M	2025-12
Waters	USD 661.85M		1.67B	2025-12